FDA Advisors Pan Drug-Coated Balloon for Lower-Leg Ischemia | MedPage Today
Drug‑coated balloons in the treatment of acute myocardial infarction (Review)
Drug-Coated Balloon
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial | SpringerLink
Peripheral Vascular Market: Drug-Coated Balloons Market Growth in 2021
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions
Drug-Coated Balloons Expand Treatment Options
In.Pact Admiral Demonstrates Durability, Safety and Efficacy at Three Years | DAIC
Frontiers | The factors influencing the efficiency of drug-coated balloons
US FDA approves first drug-coated balloon for treatment of in-stent restenosis - Vascular News
Diagnostics | Free Full-Text | The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease